Aktuellt
SENASTE
Redeye retains its positive view of Carasent following the Q4 report. Despite a somewhat softer Q4 report than expected and a softened outlook for H1 2025, we changed our Base Case driven by revised mid- and long-term assumptions.
LÄS MER
